Expertise in
5
conditions

Wenbin J. Li

Beijing, CN 
Expertise in
5
conditions
Beijing, CN 

Overview

Wenbin Li practices practicing medicine in Beijing, China.

Li is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Glioma, Gliomatosis Cerebri, Glioblastoma, and Astrocytoma.

They are actively involved in clinical research, co-authoring 109 peer reviewed articles and participating in 3 clinical trials.

Locations

Beijing, China
Other Locations
Hebei, 050000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Trial to Evaluate Safety and Efficacy pf ASC40 Tablets Combined With Bevacizumab in Subjects With Recurrent Glioblastoma
A Phase III Randomized, Double-blind, Placebo-controlled, Multi-center Trial to Evaluate Safety and Efficacy pf ASC40 Tablets Combined With Bevacizumab in Subjects With Recurrent Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: October 31, 2024
Intervention Type: Drug
Study Drugs: ASC40, Bevacizumab
Study Phase: Phase 3
A Phase I, Open-label, Dose Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas
A Phase I, Open-label, Dose Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas
Enrollment Status: Completed
Publish Date: March 04, 2020
Intervention Type: Drug
Study Phase: Phase 1
Phase 1 Trial of Tolerance and Pharmacokinetic of Chlorogenic Acid for Injection in the Advanced Glioblastoma Patients
Phase 1 Trial of Tolerance and Pharmacokinetic of Chlorogenic Acid for Injection in the Advanced Glioblastoma Patients
Enrollment Status: Completed
Publish Date: November 01, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

109 Total Publications

Advances in Pharmacological Therapy for Recurrent High-Grade Meningiomas.
Advances in Pharmacological Therapy for Recurrent High-Grade Meningiomas.
Journal: Current cancer drug targets
Published: January 21, 2026

Frequently Asked Questions about Wenbin J. Li

Is Wenbin J. Li a top-rated expert for Glioma?

MediFind is an objective health platform that identifies experts based on real-world data. Wenbin J. Li is classified as an Distinguished expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Wenbin J. Li participate in research or clinical trials?

Yes. Wenbin J. Li has published 109 articles and abstracts on conditions like Glioma. You can view a list of Wenbin J. Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Li's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile